| # | Drug | Count |
|---|---|---|
| 0 | DROSPIRENONE AND ETHINYL ESTRADIOL | 27 |
| 1 | LEVONORGESTREL | 14 |
| 2 | CISPLATIN | 13 |
| 3 | GEMCITABINE HYDROCHLORIDE | 10 |
| 4 | LEVOTHYROXINE SODIUM | 10 |
| 5 | ETONOGESTREL AND ETHINYL ESTRADIOL | 8 |
| 6 | IBUPROFEN | 8 |
| 7 | TRANEXAMIC ACID | 8 |
| 8 | ACETAMINOPHEN | 7 |
| 9 | ESCITALOPRAM | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 3 | 0.0029 |
| 1 | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | 3 | 0.0017 |
| 2 | METHYLERGONOVINE MALEATE | 1 | 0.0016 |
| 3 | FOSFOMYCIN TROMETHAMINE | 1 | 0.0016 |
| 4 | TRANEXAMIC ACID | 8 | 0.0009 |
| 5 | SODIUM FLUORIDE | 3 | 0.0008 |
| 6 | DROSPIRENONE AND ETHINYL ESTRADIOL | 27 | 0.0006 |
| 7 | DAPRODUSTAT | 1 | 0.0005 |
| 8 | PERPHENAZINE | 1 | 0.0005 |
| 9 | FEZOLINETANT | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 25 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 2 | Platinum-based Drug [EPC] | 15 |
| 3 | Progestin-containing Intrauterine System [EPC] | 14 |
| 4 | Estrogen [EPC] | 10 |
| 5 | Corticosteroid [EPC] | 9 |
| 6 | Antifibrinolytic Agent [EPC] | 8 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 7 |
| 8 | Benzodiazepine [EPC] | 6 |
| 9 | Opioid Agonist [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antifibrinolytic Agent [EPC] | 8 | 0.0008 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Oxytocic [EPC] | 1 | 0.0003 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 3 | 0.0001 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 7 | 0.0001 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Progestin [EPC] | 25 | 0.0001 |